Phase 2a Study of AdV-tk With Standard Radiation Therapy for Malignant Glioma (BrTK02)

This study is ongoing, but not recruiting participants.

Study NCT00589875 Information provided by Advantagene, Inc.

First Received: December 27, 2007 Last Updated: November 24, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	December 2011 (Final data collection date for primary outcome measure)